Press release
Life-Saving Solutions: Doxorubicin Front and Center in Market Report 2024
Doxorubicin Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $1.71 billion In 2028 At A CAGR Of 6.7%.
The doxorubicin market size has grown strongly in recent years. It will grow from $1.23 billion in 2023 to $1.32 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to chemotherapy advancements, oncology treatment standard, clinical efficacy, patient survival rates, physician recommendations.
The doxorubicin market size is expected to see strong growth in the next few years. It will grow to $1.71 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to personalized medicine advancements, targeted drug delivery systems, immunotherapy combinations, genomic and biomarker research, precision oncology growth. Major trends in the forecast period include nanotechnology integration, combination therapies, biosimilar market expansion, adjuvant therapy focus, cardioprotective interventions.
Request A Sample Of This Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=11974&type=smp
Doxorubicin Market Major Segments
The doxorubicin market covered in this report is segmented -
1) By Drug Formulation: Lyophilized Powder, Doxorubicin Injection
2) By Application: Breast Cancer, Kidney Cancer, Liver Cancer, Sarcoma, Ovarian Cancer, Lung Cancer, Leukemia, Multiple Myeloma, Other Applications
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Key Driver - Increasinng Cancer Cases Boost Doxorubicin Market
The increasing prevalence of cancer is driving the doxorubicin market forward. Cancer is a group of diseases in which cells grow abnormally and uncontrollably. Doxorubicin is a common antibiotic used in chemotherapy to treat distinct types of cancers, as it limits the growth of cancer cells by damaging their DNA. The growing incidence of cancer has led to a higher demand for doxorubicin. For instance, according to the 2021 American Cancer Society report, 1.8 million new cases of cancer diagnosed were diagnosed in 2020. Furthermore, according to September 2020 data published by the National Cancer Institute, a US-based government agency part of the National Institutes of Health, 1,806,590 new cancer cases were recorded, indicating that 43% of all cancer diagnosed in men in the United States in 2020, up from 1,752,735 in the previous year, i.e., 2019. Thus, the increasing prevalence of cancer patients is driving the doxorubicin market.
Customise This Report As Per Your Requirements -
https://www.thebusinessresearchcompany.com/Customise?id=11974&type=smp
Prominent Trend - Drug Innovation For Myeloma Treatment
Advancements in drug Investigation are a key trend gaining popularity in the doxorubicin market. Major companies in the doxorubicin market are working on innovative technologies to launch advanced products, such as injections, to sustain their position in the market. For instance, in October 2021, Padagis, a US-based healthcare company, received approval for its AB-rated generic version of Doxil (Doxorubicin Liposome Injection) from the US Food and Drug Administration, a US-based health regulatory agency. The new drug is an anthracycline topoisomerase inhibitor used for treating ovarian cancer, sarcoma, and multiple myeloma. It is also used in the treatment of multiple myeloma alongside bortezomib. Doxorubicin liposome is a cancer medication that acts as an antineoplastic agent.
Doxorubicin Market Players
Major companies operating in the doxorubicin market report are Pfizer Inc., Johnson and Johnson, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Hospira Inc., Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals, Mylan Pharmaceuticals Inc., VHB Life Sciences Limited, Xi'an International Healthcare Factory Co. Ltd., Accord Healthcare Ltd., TTY Biopharm Company Limited, Cadila Pharmaceuticals, Neon Laboratories Limited, APP Pharmaceuticals Manufacturing LLC, Sun Pharmaceutical Industries Ltd., Transo-Pharm Handels GmbH, LGM Pharma, Zhejiang Hisun Pharma, Actavis Pharma, Celon Laboratories Limited, Samarth Life Sciences Pvt. Ltd
View The Full Report Here -
https://www.thebusinessresearchcompany.com/report/doxorubicin-global-market-report
Largest And Fastest Growing Region In The Market
North America was the largest region in the doxorubicin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the doxorubicin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Doxorubicin Market Report Structure
3. Doxorubicin Market Trends And Strategies
4. Doxorubicin Market - Macro Economic Scenario
5. Doxorubicin Market Size And Growth
…..
27. Doxorubicin Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Life-Saving Solutions: Doxorubicin Front and Center in Market Report 2024 here
News-ID: 3523969 • Views: …
More Releases from The Business Research Company
Walk-In Refrigerator Market: Size, Share, Growth, Analysis, Key Players, Revenue
The new report published by The Business Research Company, titled Walk-In Refrigerator Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the walk-in refrigerator market size has grown strongly in recent years. It will grow from $11.34 billion in 2023…
Three Dimensional (3D) Integrated Circuits (IC) Market: Trends, Challenges, and …
The new report published by The Business Research Company, titled Three Dimensional (3D) Integrated Circuits (IC) Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the three dimensional (3D) integrated circuit (IC) market size has grown rapidly in recent years.…
Smart Pet Locator And Motion Detector Market: Size, Share, Growth, Analysis, Key …
The new report published by The Business Research Company, titled Smart Pet Locator And Motion Detector Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the smart pet locator and motion detector market size has grown strongly in recent years.…
Robotic Wheelchairs Market: Size, Share, Growth, Analysis, Key Players, Revenue
The new report published by The Business Research Company, titled Robotic Wheelchairs Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the robotic wheelchairs market size has grown strongly in recent years. It will grow from $11.3 billion in 2023…
More Releases for Doxorubicin
Global Doxorubicin Market Insights, Forecast
Doxorubicin is a kind of antitumor antibiotics, can inhibit the synthesis of RNA and DNA, RNA in the strongest inhibitory effect. Doxorubicin has an effect on a wide variety of tumor, belongs to the cycle non-specific drug, have all sorts of growth cycle of tumor cells to kill.it's given by injection into a vein. The global Doxorubicin market is valued at 910 million US$ in 2018 and will reach 1410…
Doxorubicin Global Industry Report - History, Present and Future 2019
The global market size of Doxorubicin is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.
There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.
For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from…
Doxorubicin Market Report Explored in Latest Research 2025
Doxorubicin is the generic drug name for anti-cancer chemotherapy drug Adriamycin and Rubex. Doxorubicin is an anthracycline antibiotic and belongs to the group of anti-cancer medication known as antineoplastic and is made from the natural product produced by bacterium Streptomyces peucetius var. caesius.
Request Brochure-
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26138
It is used for the treatment of different types of cancer including breast, stomach, ovary, bone, testicles, bladder, lung, soft tissue, osteogenic sarcoma, Wilms’ tumor, and Hodgkin’s…
Doxorubicin Market to Reflect Steady Growth Rate by 2024
Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). Anthracycline especially doxorubicin has been the mainstay of cancer treatment since many years. Doxorubicin also known as doxorubicin hydrochloride is an antibiotic belonging to class of medication known as anthracycline antibiotics, and is the first liposomal encapsulated anticancer drug to receive clinical approval and is used in the…
Doxorubicin Market to Witness an Outstanding Growth by 2024
Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). Anthracycline especially doxorubicin has been the mainstay of cancer treatment since many years. Doxorubicin also known as doxorubicin hydrochloride is an antibiotic belonging to class of medication known as anthracycline antibiotics, and is the first liposomal encapsulated anticancer drug to receive clinical approval and is used in the…
Doxorubicin Market Rugged Expansion Foreseen by 2024
Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). Anthracycline especially doxorubicin has been the mainstay of cancer treatment since many years. Doxorubicin also known as doxorubicin hydrochloride is an antibiotic belonging to class of medication known as anthracycline antibiotics, and is the first liposomal encapsulated anticancer drug to receive clinical approval and is used in the…
